Conmed (CNMD) Enterprise Value (2010 - 2026)

Conmed has reported Enterprise Value for 17 years, with the latest figure at -$35.0 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value rose 1.28% year-over-year to -$35.0 million; the trailing twelve-month figure through Mar 2026 stood at -$35.0 million (up 1.28% YoY), and the FY2025 full-year result was -$40.8 million, down 66.88% from the prior year.
• Enterprise Value for Q1 2026 stood at -$35.0 million, up from -$40.8 million in the prior quarter.
• The five-year high for Enterprise Value was -$24.3 million in Q4 2023, with the low at -$53.2 million in Q2 2022.
• Historically, Enterprise Value has averaged -$32.9 million across 5 years, with a median of -$33.4 million in 2022.
• Annual changes were most pronounced in 2023 — Enterprise Value soared 47.61% — and 2025, when it sank 66.88%.
• Conmed's Enterprise Value stood at -$28.9 million in 2022, then grew by 16.05% to -$24.3 million in 2023, then decreased by 0.67% to -$24.5 million in 2024, then tumbled by 66.88% to -$40.8 million in 2025, then grew by 14.18% to -$35.0 million in 2026.
• The last three Enterprise Value figures came in at -$35.0 million (Q1 2026), -$40.8 million (Q4 2025), and -$38.9 million (Q3 2025), per Business Quant data.